Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Splenomegaly 1Primary Myelofibrosis 1Neoplasm Metastasis 1Melanoma 1Leukemia 1Epidermolysis Bullosa Dystrophica 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Anemia 1Adenocarcinoma 1

Interventions

Surveys and Questionnaires 2Ritonavir 1Quality of Life 1ON 01910 1Nivolumab 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Splenomegaly × ON 01910 × Clear all
NCT02730884 2020-08-07

Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 6 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Splenomegaly, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡